Live Quote · NASDAQGOVXHealthcare· Biotechnology

GeoVax Labs, Inc.

$1.19 5.56%($-0.07)
TickerSpark Score
55/100
Mixed
80
Valuation
40
Profitability
55
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GOVX research report →

52-Week Range1% of range
Low
$0.96
Current
$1.19
High
$23.10
Company Overviewwww.geovax.com

About the company

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform.

CEO
David Alan Dodd
IPO
2020
Employees
17
HQ
Smyrna, GA, US

Price Chart

-90.02% · this period
$21.27$11.16$1.05Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.14M
P/E
-0.05
P/S
1.34
P/B
4.84
EV/EBITDA
-0.01
Div Yield
0.00%
Profitability
Gross Margin
103.96%
Op Margin
-2523.43%
Net Margin
-2507.27%
ROE
-709.51%
ROIC
-2421.00%
Growth & Income
Revenue
$2.49M · -37.06%
Net Income
$-21,464,771 · 14.11%
EPS
$-22.40 · 81.41%
Op Income
$-21,639,047
FCF YoY
12.94%
Performance & Tape
52W High
$23.10
52W Low
$0.96
50D MA
$1.59
200D MA
$5.61
Beta
3.63
Avg Volume
5.13M

Get TickerSpark's AI analysis on GOVX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 17, 26SPENCER JOHN N JRother6,000
Jun 17, 26Morgan Jayneother6,000
Jun 17, 26MCNALLY ROBERT Tother6,000
Jun 17, 26Lemerond Nicoleother6,000
Jun 17, 26Kollintzas Dean Gother6,000
Jun 17, 26CHASE RANDAL Dother6,000
Jun 17, 26Sharkey John W.other17,600
Jun 17, 26Reynolds Markother17,600
Jun 17, 26NEWMAN MARK Jother17,600
Jun 17, 26McKee Kelly T. Jr.other17,600
Coverage · GOVX

Our GOVX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on GOVX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate GOVX report →
Internal Compare

Similar companies

Peers in the same neighborhood.